Quail Springs ag education facility trying to buy land it is on
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Pot rules vary across Tri-Counties
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Shellfish farmers worry that fisheries could be closed again
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
3rd quarter sales take off for missile defense company
Defense and intelligence company Raytheon, which has large operations in Goleta, reported a 4.5 percent increase in sales for the third quarter of 2017, for a net income of $572 million. The missile systems segment led the company’s growth, with a 10 percent increase in net sales to $1.95 billion, and integrated defense systems rose Read More →
MindBody creeps closer toward profitability
MindBody’s revenues continued its double-digit growth, and net losses fell by almost half to $3.6 million for the quarter ended Sept. 30. The San Luis Obispo-based software provider for the wellness and fitness industry saw a trickle of operating profits during the quarter. Excluding stock-based compensation and amortization of certain assets, the company posted a Read More →
Deckers halts sale hunt against investors’ wishes
Footwear manufacturer Deckers Brands will launch a $400 million share buyback program as it wrapped up a strategic business review and simultaneously reported a 26 percent increase in its second quarter net income. In an earnings conference call on Oct. 26, the Goleta-based company said that it would no longer actively pursue a sale or Read More →
Amgen product sales slip but income stays steady
Net income at biotech giant Amgen stayed flat for the third quarter, despite a slight downtick in revenues to $5.8 billion, the company reported Oct. 25. Product sales saw a slight decline, including Neupogen, Epogen and its blockbuster rheumatoid arthritis drug Enbrel, which fell 6 percent, but net income stayed steady at a little more Read More →
